Your trusted source for investing success

Tag: healthcare

5 Top Biotech Stocks on the TSX Year-to-date

5 Top Biotech Stocks on the TSX Year-to-date

The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.

Q BioMed Announces Development Partnership With Sphaera Pharma

Q BioMed Announces Development Partnership With Sphaera Pharma

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company, announced today a partnership with Sphaera Pharma to develop a new and proprietary analog of QBM-001 for pediatric developmental nonverbal disorder.

 “The goal of our collaboration with Sphaera Pharma is to put the patient first, especially since QBM-001 targets a rare subset of toddlers

TrackX Begins Phase II of Vehicle Management Solution for Carvana, Expanded capabilities Include Tracking of Carvana’s Vehicle Repair and Maintenance

TrackX Begins Phase II of Vehicle Management Solution for Carvana, Expanded capabilities Include Tracking of Carvana’s Vehicle Repair and Maintenance

TrackX Holdings Inc. (TSX.V: TKX) (“TrackX” or the “Company”), an enterprise IIoT software platform provider for the management of physical assets, is pleased to announce the completion of Phase I of its national roll-out with Carvana (NYSE: CVNA), a leading eCommerce platform for buying used cars. Carvana uses advanced, proprietary

WeedMD Retains Stoic Advisory to Accelerate Corporate Initiatives

WeedMD Retains Stoic Advisory to Accelerate Corporate Initiatives

WeedMD Inc. (TSX-V:WMD),, a federally licensed producer and distributor of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), is pleased to announce it has entered into a consulting services agreement with Stoic Advisory Inc. (“Stoic”), to support the Company with ongoing business development initiatives and capital markets

TECSYS Reports Financial Results for First Quarter Fiscal 2018

TECSYS (TSX:TCS) has announced its results for the fiscal year 2018, ended July 31, 2017.

As quoted in the press release:
 All dollar amounts are expressed in Canadian currency and are prepared in accordance with International Financial Reporting Standards (IFRS) and are unaudited.

“The first quarter of our fiscal year covers the summer

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Top Biotech Stocks on the TSX Year-to-date

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/top-biotech-stocks-tsx/